| Primary |
| Asthma |
54.3% |
| Chronic Obstructive Pulmonary Disease |
9.3% |
| Bronchitis |
4.9% |
| Hypertension |
4.9% |
| Emphysema |
3.2% |
| Dyspnoea |
2.8% |
| Cancer Pain |
2.0% |
| Insomnia |
2.0% |
| Pulmonary Hypertension |
2.0% |
| Blood Cholesterol Increased |
1.6% |
| Diabetes Mellitus |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Pregnancy |
1.6% |
| Schizophrenia |
1.6% |
| Bronchiectasis |
1.2% |
| Gastritis |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Lung Disorder |
1.2% |
| Alcohol Abuse |
0.8% |
| Allergic Bronchitis |
0.8% |
|
| Dyspnoea |
21.9% |
| Drug Ineffective |
7.8% |
| Intentional Drug Misuse |
7.8% |
| Pneumonia |
7.8% |
| Tremor |
7.8% |
| Tachycardia |
4.7% |
| Venous Occlusion |
4.7% |
| Wheezing |
4.7% |
| Asthma |
3.1% |
| Deep Vein Thrombosis |
3.1% |
| Epilepsy |
3.1% |
| Lung Neoplasm Malignant |
3.1% |
| Myocardial Infarction |
3.1% |
| Pulmonary Congestion |
3.1% |
| Pyrexia |
3.1% |
| Rash |
3.1% |
| Weight Decreased |
3.1% |
| Acute Psychosis |
1.6% |
| Adrenal Suppression |
1.6% |
| Ageusia |
1.6% |
|
| Secondary |
| Asthma |
58.1% |
| Pulmonary Hypertension |
6.2% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Bronchitis |
3.7% |
| Hypertension |
3.7% |
| Schizophrenia |
3.3% |
| Allergic Bronchitis |
2.5% |
| Blood Triglycerides Increased |
2.5% |
| Atrial Fibrillation |
1.7% |
| Hypersensitivity |
1.7% |
| Dyspnoea |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Alcohol Abuse |
0.8% |
| Alopecia |
0.8% |
| Angina Pectoris |
0.8% |
| Arthritis |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Diarrhoea |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
|
| Dyspnoea |
10.4% |
| Wheezing |
10.4% |
| Drug Ineffective |
8.3% |
| Intentional Drug Misuse |
8.3% |
| Speech Disorder |
6.3% |
| Tremor |
6.3% |
| Visual Field Defect |
6.3% |
| Asthma |
4.2% |
| Cryptogenic Organising Pneumonia |
4.2% |
| Drug Effect Decreased |
4.2% |
| Hypercapnia |
4.2% |
| Pulmonary Congestion |
4.2% |
| Tendonitis |
4.2% |
| Therapy Cessation |
4.2% |
| Throat Irritation |
4.2% |
| Deafness |
2.1% |
| Gait Disturbance |
2.1% |
| Headache |
2.1% |
| Hypersensitivity |
2.1% |
| Hypersensitivity Vasculitis |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Hypertension |
11.4% |
| Chronic Obstructive Pulmonary Disease |
9.0% |
| Ill-defined Disorder |
7.2% |
| Neuritis |
7.2% |
| Asthma |
5.4% |
| Osteoporosis |
4.2% |
| Depression |
3.0% |
| Drug Use For Unknown Indication |
3.0% |
| Lumbar Spinal Stenosis |
3.0% |
| Plasma Cell Myeloma |
3.0% |
| Atrial Fibrillation |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Pain |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| Arthritis |
1.8% |
| Dyslipidaemia |
1.8% |
| Emphysema |
1.8% |
| Hiv Infection |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
|
| Vomiting |
13.8% |
| Intestinal Obstruction |
6.9% |
| Myalgia |
6.9% |
| Pneumonia |
6.9% |
| Positron Emission Tomogram Abnormal |
6.9% |
| Urinary Retention |
6.9% |
| Urticaria |
6.9% |
| Axonal Neuropathy |
3.4% |
| Colitis Ischaemic |
3.4% |
| Delirium |
3.4% |
| Dizziness |
3.4% |
| Drug Interaction |
3.4% |
| Hypertension |
3.4% |
| Hypoglycaemia |
3.4% |
| Hyponatraemia |
3.4% |
| Hypophosphataemia |
3.4% |
| Inappropriate Schedule Of Drug Administration |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Intraocular Pressure Increased |
3.4% |
| Ischaemic Stroke |
3.4% |
|
